Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial, Dose Finding Combination Chemotherapy With PegLiposomal Doxorubicin (PLD) And Carboplatin In Patients With Gynecologic Tumors

NCT00032162 is registered in ClinicalTrials.gov with AGO Study Group as lead sponsor.

NCT NCT00032162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00032162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial, Dose Finding Combination Chemotherapy With PegLiposomal Doxorubicin (PLD) And Carboplatin In Patients With Gynecologic Tumors
Lead sponsor
AGO Study Group
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2001
Completion date
Not reported
Enrollment
63 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, fallopian tube cancer, ovarian cancer, sarcoma